You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Papillary Renal Cell Carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Papillary Renal Cell Carcinoma Trial (Pembrolizumab, Placebo)

Not yet recruiting
  • Papillary Renal Cell Carcinoma
  • (no location specified)
Nov 24, 2023

Advanced Clear Cell Renal Carcinoma (Ccrcc), Papillary Renal Cell Carcinoma (Prcc) Trial run by the National Cancer Institute

Not yet recruiting
  • Advanced Clear Cell Renal Carcinoma (Ccrcc)
  • Papillary Renal Cell Carcinoma (Prcc)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Clinical Factors on Prognosis of Papillary Renal Cell Carcinoma

Completed
  • Carcinoma, Renal Cell
  • We do not have any interventions. This study is based on obseravation.
  • (no location specified)
Oct 27, 2023

Carcinoma, Renal Cell Trial (Orellanine)

Not yet recruiting
  • Carcinoma, Renal Cell
  • (no location specified)
Jan 25, 2023

Advanced Clear Cell Renal Cell Carcinoma, Advanced Papillary Renal Cell Carcinoma, Advanced Renal Cell Carcinoma Trial in Duarte

Recruiting
  • Advanced Clear Cell Renal Cell Carcinoma
  • +11 more
  • Cabozantinib S-malate
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Nov 22, 2022

Papillary Renal Cell Carcinoma Type 2 Trial in France (Axitinib Oral Tablet [Inlyta], Pembrolizumab Injection [Keytruda])

Recruiting
  • Papillary Renal Cell Carcinoma Type 2
  • Axitinib Oral Tablet [Inlyta]
  • Pembrolizumab Injection [Keytruda]
  • Angers, France
  • +11 more
Aug 26, 2022

Kidney Cancer, Renal Cell Carcinoma, Clear Cell Carcinoma Trial in Dallas (13C-Glucose, 13C-Acetate, 13C-Lactate)

Recruiting
  • Kidney Cancer
  • +11 more
  • 13C-Glucose
  • +4 more
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Dec 1, 2022

Renal Cell Carcinoma, Papillary Renal Cell Carcinoma Type 1, Papillary Renal Cell Carcinoma Type 2 Trial in Australia

Recruiting
  • Renal Cell Carcinoma
  • +5 more
  • Albury, New South Wales, Australia
  • +10 more
Feb 14, 2022

Clear Cell Papillary Renal Tumor, Collecting Duct Carcinoma, Hereditary Leiomyomatosis and Renal Cell Carcinoma Trial in Los

Recruiting
  • Clear Cell Papillary Renal Neoplasm
  • +10 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Oct 25, 2021

Renal Clear Cell Carcinoma, Renal Papillary Cell Carcinoma Trial in London (Savolitinib, MEDI4736, Tremelimumab)

Active, not recruiting
  • Renal Clear Cell Carcinoma
  • Renal Papillary Cell Carcinoma
  • London, United Kingdom
    Thomas Powles
Aug 10, 2022

Renal Cell Carcinoma, Papillary Renal Cell Carcinoma Type 1, Papillary Renal Cell Carcinoma Type 2 Trial in Australia

Active, not recruiting
  • Renal Cell Carcinoma
  • +5 more
  • Albury, New South Wales, Australia
  • +18 more
Feb 14, 2022

Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma, Unclassified Renal Cell Carcinoma, Papillary Renal Cell Carcinoma

Recruiting
  • Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma
  • +6 more
  • Basking Ridge, New Jersey
  • +6 more
Feb 2, 2022

Metastatic Papillary Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v8 Trial (Atezolizumab, Cabozantinib S-malate)

Recruiting
  • Metastatic Papillary Renal Cell Carcinoma
  • Stage IV Renal Cell Cancer AJCC v8
  • Atezolizumab
  • +4 more
  • Sacramento, California
  • +38 more
Jan 17, 2023

Kidney Cancer Trial run by the NCI (INC280)

Completed
  • Kidney Cancer
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 18, 2021

Clear Cell Kidney Cancer, Kidney Cancer, Kidney Cancer With PBRM1/BAP1/VHL/SETD2 Mutations Trial (Axitinib 5 MG)

Available
  • Clear Cell Kidney Cancer
  • +2 more
  • Axitinib 5 MG
  • (no location specified)
Jul 3, 2023

Renal Cell Carcinoma, Hereditary Leiomyomatosis, Renal Cell Cancer Trial run by the NCI (Vandetanib, Metformin,

Terminated
Has Results
  • Renal Cell Carcinoma
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 12, 2021

Advanced Renal Cell Carcinoma, Chromophobe Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma Trial in United States (drug,

Recruiting
  • Advanced Renal Cell Carcinoma
  • +8 more
  • Cabozantinib S-malate
  • +3 more
  • Birmingham, Alabama
  • +35 more
Jan 24, 2023

Carcinoma, Carcinoma, Renal Cell, Kidney Tumors Trial in Worldwide (Savolitinib, Sunitinib)

Active, not recruiting
Has Results
  • Carcinoma
  • +7 more
  • La Jolla, California
  • +58 more
Jan 13, 2023

Papillary Renal Cell Cancer Trial in Worldwide (AZD6094)

Completed
Has Results
  • Papillary Renal Cell Cancer
  • Birmingham, Alabama
  • +22 more
Mar 23, 2021

Locally Advanced and/or Metastatic Anaplastic Large Cell Lymphoma, Locally Advanced and/or Metastatic Inflammatory

Active, not recruiting
  • Locally Advanced and/or Metastatic Anaplastic Large Cell Lymphoma
  • +5 more
  • Crizotinib (PF-02341066)
  • Brussels, Belgium
  • +24 more
May 9, 2022

Non-clear Renal Cell Carcinoma Trial in Nanjing, Nanning (Toripalimab, Axitinib)

Recruiting
  • Non-clear Renal Cell Carcinoma
  • Nanjing, Jiangsu, China
  • +1 more
Mar 13, 2023

Kidney Cancer Trial in France (sunitinib malate)

Completed
  • Kidney Cancer
  • sunitinib malate
  • Angers, France
  • +21 more
Feb 18, 2021

Carcinoma, Renal Cell, Renal Cell Carcinoma of Papillary Histology, Renal Cell Carcinoma With Clear Cell Histology Trial in

Completed
  • Carcinoma, Renal Cell
  • +3 more
  • Ann Arbor, Michigan
  • +8 more
Dec 16, 2020

Biomarkers of Renal Cancer

Recruiting
  • Renal Cell Carcinoma
  • +3 more
    • Firenze, Italy
    • +3 more
    Mar 14, 2023

    Papillary Renal Cell Carcinoma Trial in France (axitinib)

    Completed
    • Papillary Renal Cell Carcinoma
    • Angers, France
    • +9 more
    Feb 19, 2020